Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib randomized withdrawal trial in neuropathic pain
2010-022873-32Phase 4Terminated
- Sponsor
- Analgesic Solutions
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Neuralgia, postherpetic neuralgia (PHN), diabetic neuropathy and 2 more comparing Etoricoxib (Arcoxia) with Placebo (2 arms). Primary endpoint: Time to Efficacy Failure. Started Oct 2010; status: terminated.
02
Drugs
etoricoxib
03
Conditions
Neuralgiapostherpetic neuralgia (PHN)diabetic neuropathysmall fiber neuropathy (SFN)Sensory neuropathy (SN)
Beyond the preview
Go deeper on 2010-022873-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022873-32.